Modafinil

Source: Wikipedia, the free encyclopedia.

Modafinil
Clinical data
Trade namesProvigil, Alertec, Modavigil, others
Other namesCRL-40476; Diphenylmethyl-sulfinylacetamide
AHFS/Drugs.comMonograph
MedlinePlusa602016
License data
Pregnancy
category
Dependence
liability		Relatively low[2]
Addiction
liability		Low[2]
Routes of
administration		By mouth[3]
Drug classCNS stimulant
eugeroic
ATC code
Legal status
Legal status
Pharmacokinetic data
Protein binding62.3%
MetabolismLiver (primarily via amide hydrolysis);[9] CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5 involved[11]
Elimination half-life12–15 h[9]
Duration of action11.5 h[10]
ExcretionUrine (80%)
Identifiers
  • 2-(diphenylmethanesulfinyl)acetamide
JSmol)
  • O=S(C(c1ccccc1)c2ccccc2)CC(=O)N
  • InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17) checkY
  • Key:YFGHCGITMMYXAQ-UHFFFAOYSA-N checkY
  (verify)

Modafinil, sold under the brand name Provigil among others, is a wakefulness-promoting

by mouth.[3][8] Modafinil is not approved by the US Food and Drug Administration (FDA) for use in people under age 17.[8]

Modafinil has potential for causing severe

abuse.[3][8][12] Modafinil may harm the fetus if taken during or two months prior to pregnancy.[13]

While modafinil is used as a cognitive enhancer or "smart drug" among healthy individuals seeking improved focus and productivity,[14][15] its use outside medical supervision raises concerns regarding potential misuse or abuse.[3][8][16] Research on the cognitive enhancement effects of modafinil in non-sleep-deprived individuals has yielded mixed results, with some studies suggesting modest improvements in attention and executive functions, while others show no significant benefits or even a decline in cognitive functions.[17][18]

Usage

Medical

Sleep disorders

Modafinil, a

central nervous system (CNS) stimulant (psychostimulant) itself, modafinil has lower addictive potential than classical psychostimulants, such as amphetamines, cocaine or methylphenidate,[10][20][21] but still produces psychoactive, euphoric, and subjective effects typical of classical stimulants.[3][8][16]

Narcolepsy causes a strong urge to sleep during the day and can include symptoms like cataplexy (sudden muscle weakness), sleep paralysis (inability to move or speak while falling asleep or waking up), and

hypocretin (or orexin), primarily produced in the hypothalamus.[22][23] Modafinil is not a cure for narcolepsy, but it can help manage the symptoms. While modafinil is primarily used to treat excessive sleepiness, it may also help reduce the frequency and severity of cataplexy attacks in some people. Modafinil is approved for management of narcolepsy with or without cataplexy. However, it is not specifically approved for the treatment of cataplexy.[24][25]

Modafinil is also prescribed for shift work sleep disorder and excessive daytime sleepiness caused by obstructive sleep apnea, though it is recommended that people with apnea use continuous positive airway pressure (CPAP) therapy, that is a sleep breathing apparatus to prevent apnea, before starting modafinil.[8][18][26]

Modafinil's use varies by region. In the US, it is approved for adult narcolepsy, shift work sleep disorder, and obstructive sleep apnea, but not for children.[16] In the UK and the EU, since 2014, it is approved solely for narcolepsy, including in children (pediatric narcolepsy), with its use for other conditions restricted by the European Medicines Agency.[24][27]

As of 2024, both the French and the American Academy of Sleep Medicine strongly recommend modafinil as the first-choice treatment for narcolepsy.[28] In Europe, modafinil is considered one of the primary drugs recommended for treating narcolepsy according to the guidelines.[29]

Multiple sclerosis-related fatigue

The National Institute for Health and Care Excellence (NICE) in the UK, along with various non-governmental organizations focused on multiple sclerosis (MS), endorse the off-label use of modafinil to alleviate fatigue associated with MS.[16][30][31]

MS-related fatigue is a common and often debilitating symptom experienced by people with multiple sclerosis.[32][33][34][35] It can significantly impact their daily functioning, quality of life, and ability to perform everyday activities. When prescribed for MS-related fatigue management, modafinil works by promoting wakefulness and increasing alertness without causing drowsiness or disrupting nighttime sleep. People with multiple sclerosis often report increased energy levels, reduced feelings of tiredness, improved cognitive function, and an overall improvement in their quality of life when taking modafinil. While modafinil can provide relief from MS-related fatigue symptoms, it does not treat the underlying cause or cure MS itself. The primary goal of using modafinil in MS is symptom management and improving daily functioning.[34][35][36] The effects of modafinil on other aspects of MS-related fatigue, such as severity and cognitive function, are less clear.[37]

While modafinil has been shown to be effective in managing fatigue in people with MS, optimal dosing and treatment schedules are not well established.[34][35][36][37]

Attention deficit hyperactivity disorder

See also: § Attention deficit hyperactivity disorder (research)

Modafinil is occasionally prescribed

off-label for individuals with attention deficit hyperactivity disorder (ADHD).[38][39][40] It has not consistently shown efficacy in treating adult ADHD, especially when compared to other treatments such as lisdexamfetamine.[41][42] In children, modafinil is efficient in treating ADHD symptoms.[43][44]

Given its approved status in the US to treat narcolepsy, physicians can also prescribe modafinil for off-label uses, such as treating ADHD in both children and adults.[45][46][47]

The Canadian Network for Mood and Anxiety Treatments (CANMAT) suggests modafinil as a second-line choice for ADHD, after the first-line choices such as bupropion are exhausted.[48]

Bipolar disorder

Modafinil is used off-label as an

adjunctive treatment (i.e., in combination therapy) for acute depressive phase in bipolar disorder.[49][50][51][52] The depressive phase of bipolar disorder may feature excessive sleepiness and fatigue. Adjunctive treatment with modafinil can be used as an augmentation for the main treatment to increase its effect and is safe and effective, especially for people who do not respond well to standard antidepressants.[53][54][55] Modafinil does not significantly increase the risk of mood switch to mania or suicide attempts in people with bipolar disorder.[56][53] Modafinil may also have cognitive benefits in people with bipolar disorder who are in a remission state.[57][58][55]

Whereas modafinil and armodafinil are approved for narcolepsy, they have been repurposed as

adjunctive treatments to alleviate symptoms of acute depressive phase in people with bipolar disorder.[59] Drug repurposing in psychiatry is a strategy for discovering new uses for drugs that have already been approved or tested in clinical trials for other illnesses. As such, drug repurposing is a rapid, cost-effective, and reduced-risk strategy for the development of new treatment options for psychiatric disorders.[59] 2021 meta-analysis concluded that add-on modafinil and armodafinil were more effective than placebo on response to treatment, clinical remission, and reduction in depressive symptoms, with only minor side effects, but the effect sizes are small and the quality of evidence is therefore low, limiting the clinical relevance of the evidence.[59][60] Very low rates of mood swing (a change in mood from one extreme to another)[56][61] have been observed with modafinil and armodafinil in depressive phase of bipolar disorder.[51][62]

Occupational

See also:
List of drugs used by militaries and Space medicine

Modafinil was used by the French Foreign Legion,[63] U.S. Air Force,[64][65] and U.S. Marine[66] infantry during the Gulf War to enhance "operational tempo" (a term that denotes the speed and intensity at which military operations or activities are executed), aiming to optimize the overall performance and efficiency of the unit.[65][67][68]

Armed forces in various countries, including the United States, the United Kingdom, India, and France, have considered modafinil as an alternative to traditional amphetamines for managing sleep deprivation in combat or extended missions.[69] The US military approved modafinil for specific Air Force missions, replacing amphetamines for fatigue management.[70] The use of modafinil in military contexts without sleep deprivation is not recommended due to inconclusive evidence on its cognitive enhancement benefits and potential risks of adverse effects.[64]

Modafinil is also available to astronauts aboard the International Space Station for the management of fatigue caused by circadian dyssynchrony in orbit.[71]

Non-medical

See also: § Cognitive enhancement

Modafinil has been used non-medically as a "smart drug"

transhumanists,[75][76] and professionals in various sectors. Its use is attributed by these individuals to its potential for enhancing attention, cognitive capabilities, and alertness.[77][78]

The effectiveness of modafinil as cognitive enhancer is still debated. Some studies suggest significant increases in cognitive abilities, while others indicate mild to non existent cognitive improvements.[79][80][49][81] In some cases, it has even been associated with impairments in certain cognitive functions.[17][18][82] It has been shown that modafinil's positive impact on cognitive abilities is more noticeable on sleep deprived individuals.[83] Therefore, in people who are not sleep-deprived, the potential of modafinil as a cognitive enhancer may be limited.[84]

Available forms

Modafinil tablets – Modalert 200

Modafinil is commercially available in 100 mg and 200 mg oral tablet forms.[8] Additionally, it is offered as the (R)-enantiomer, known as armodafinil, and as a prodrug named adrafinil.[85]

Contraindications

Modafinil is contraindicated during pregnancy and 2 months before getting pregnant.[86] Women who take modafinil should not become pregnant, and, additionally, should be aware that modafinil reduces effectiveness of hormonal contraceptives, increasing chances of getting pregnant.[8][12][87] Modafinil therapy during pregnancy increases the risk of birth defects,[13][88][89][86] such as with congenital torticollis, hypospadias, and congenital heart defects.[88]

Modafinil is contraindicated for individuals with known hypersensitivity to either modafinil or armodafinil.[8][10]

Modafinil is also contraindicated in certain cardiac conditions, including uncontrolled moderate to severe hypertension, arrhythmia, cor pulmonale,[90][91] and in cases with signs of CNS stimulant-induced mitral valve prolapse or left ventricular hypertrophy.[92][93] The package insert in the United States cautions about using modafinil in people with a documented medical history of left ventricular hypertrophy or those diagnosed with mitral valve prolapse who have previously exhibited symptoms associated with the mitral valve prolapse syndrome while undergoing treatment involving central nervous system stimulants.[94] The reasons why modafinil is contraindicated in certain cardiac conditions are because modafinil affects the autonomic nervous system and, in particular, exerts significant effects on autonomic cardiovascular regulation, leading in some people to notable increases in heart rate and blood pressure. These substantial changes in the autonomic system warrant careful consideration when prescribing modafinil to people with pre-existing cardiovascular conditions.[95] The increase in heart rate and blood pressure can worsen the symptoms of such pre-existing conditions as hypertension, arrhythmia, and cor pulmonale. These changes in the autonomic system induced by modafinil can increase the risk of heart attack, stroke, and heart failure. Modafinil can stimulate the release of norepinephrine and epinephrine, hormones that activate the sympathetic nervous system. This can cause vasoconstriction, which is the narrowing of blood vessels, and increase the heart's workload, which is not desired in people with pre-existing heart conditions. In particular, modafinil can worsen the consequences of mitral valve prolapse or left ventricular hypertrophy, which are structural abnormalities of the heart. These can affect the blood flow and oxygen delivery to the heart and other organs.[96]

Modafinil is also contraindicated in people with congenital problems like

lactase deficiency, or glucose-galactose malabsorption.[97][90][91]

Adverse effects

Modafinil is generally well-tolerated but can have potential risks and side effects. Common adverse effects of modafinil, experienced by less than 10% of users, include headaches, nausea, and reduced appetite.[98][99][16] Anxiety, insomnia, dizziness, diarrhea, and rhinitis are also reported in 5% to 10% of users.[16] Psychiatric reactions have occurred in individuals with and without a preexisting psychiatric history.[100]

No significant changes in body weight have been observed in clinical trials, although decreased appetite and weight loss have been noted in children and adolescents.[101] Modafinil can cause a slight increase in aminotransferase enzymes, indicative of liver function, but there is no evidence of serious liver damage when levels are within reference ranges.[102]

Rare but serious adverse effects include severe skin rashes and allergy-related symptoms. Between December 1998 and January 2007, the FDA received reports of six cases of severe cutaneous adverse reactions, including

DRESS syndrome. The FDA has issued alerts regarding these risks and also noted reports of angioedema and multi-organ hypersensitivity reactions in postmarketing surveillance.[103][104] In 2007, the FDA required Cephalon to modify the Provigil leaflet to include warnings about these serious conditions. The long-term safety and effectiveness of modafinil have not been conclusively established.[105]

The FDA does not endorse modafinil for children's medical conditions due to an increased risk of rare but serious dermatological toxicity, manifested as Stevens–Johnson syndrome which is a type of severe skin reaction.[106][57][107] However, in Europe, modafinil may be prescribed for treating narcolepsy in children.[108]

Drug tolerance

Extensive clinical research has not demonstrated drug tolerance, defined as a reduction in response, to wakefulness-promoting and anti-fatigue properties of modafinil, even with therapeutic use extending up to 40 weeks.[109][110][105]

While modafinil is generally found to be safe and significant adverse effects are rare, including in pediatric narcolepsy cases (sleep disorders in children), there is evidence that long-term usage can lead to tolerance in some individuals.[18] This necessitates higher doses to maintain the same level of cognitive enhancement or relief from sleepiness.[18]

People with current or past substance addictions and those with a family history of addiction are particularly at risk for developing tolerance.[18][108][111]

The mechanisms driving tolerance to modafinil, which may involve its impact on dopamine and norepinephrine levels in the brain, are not fully understood.[18][108][111]

Repeated administration of modafinil for off-label use, such as increased alertness and cognitive-enhancing effects in sleep deprivation, can lead to drug tolerance, which means that the effectiveness of the drug may decrease over time. Still, modafinil therapy as a eugeroic agent to treat narcolepsy does not typically lead to drug tolerance, i.e., the effectiveness does not usually decrease on prolonged use, although individual responses may vary.[18][108][111]

Addiction and dependence

Despite being a

mood-elevating properties.[8] The similarities in effects with caffeine are not clearly established.[10][114] Unlike other stimulants, modafinil does not induce a strong subjective feeling of pleasure or reward, which is commonly associated with euphoria, an intense feeling of well-being.[18] Euphoria is a potential indicator of drug abuse, which is the compulsive and excessive use of a substance despite adverse consequences.[115] In comparison to classical stimulants, modafinil exhibits a low propensity for abuse, as it lacks significantly expressed pleasurable or euphoric effects.[18] Albeit to a lower degree than classical stimulants, modafinil still produces psychoactive, euphoric, and subjective effects typical for abused stimulants.[8][3]

Modafinil was not observed to promote overuse or misuse, even in people who have a history of cocaine addiction.[116] Despite the initial belief that modafinil carried no abuse potential, emerging evidence suggests that it works at the same neurobiological mechanisms as other addictive stimulants. Consequently, there exists a potential risk of modafinil abuse, necessitating prudent consideration and caution when prescribing or using this medication.[84] Modafinil exhibits a lower response on the amphetamine scale of the addiction research center inventory, suggesting reduced propensity for abuse compared to amphetamine.[117]

The US Drug Enforcement Administration has classified modafinil as a Schedule IV controlled substance;[2][8] the medicine is recognized for having valid medical uses with low addiction potential.[112][45] The International Narcotics Control Board does not classify it as a narcotic or a psychotropic substance.[118][119]

Overdose

An overdose of modafinil can lead to a range of symptoms and complications. Psychiatric symptoms may include psychosis, mania, hallucinations, and suicidal ideation, which can occur even in individuals without a history of mental illness and may persist after discontinuation of the drug.[120] Neurological complications, such as seizures, tremors, dystonia, and dyskinesia, may arise from modafinil's interaction with various neurotransmitter systems.[120]

Allergic reactions such as rash, angioedema, anaphylaxis, and Stevens–Johnson syndrome may be triggered by an immunological response to modafinil or its metabolites.[121][122] Cardiovascular complications like hypertension, tachycardia, chest pain, and arrhythmias may also be observed due to modafinil's sympathomimetic action.[120]

In animal studies, the median lethal dose (LD50) of modafinil varies among species and depends on the route of administration. In mice and rats, the LD50 is approximately 1250 mg/kg if administered via an injection, but the oral LD50 for rats is 3400 mg/kg.

gastrointestinal disturbances.[8][125]

The management of modafinil overdose involves supportive care, monitoring of vital signs, and treatment of specific complications. In cases of recent consumption,

activated charcoal, gastric lavage, or hemodialysis may be used.[120] There is no specific antidote for modafinil overdose.[125][126][127] The main way to deal with modafinil overdose is supportive care, which includes sedating the patient and stabilizing their blood pressure, and muscle activity in case of manifestations such as agitation or tremor.[125]

Interactions

Some of the drugs that frequently interact with modafinil include aripiprazole (an antipsychotic), amphetamine (including its enantiomers and salts; stimulants), aspirin, diphenhydramine (an antihistamine), and others.[128]

Modafinil is a weak to moderate inducer of CYP3A4[87][129][130] and a weak inhibitor of CYP2C19, enzymes of the cytochrome P450 group of enzymes.[16] Modafinil also induces or inhibits other cytochrome P450 enzymes.[87] One in vitro study predicts that modafinil may induce the cytochrome P450 enzymes CYP1A2, CYP3A4, and CYP2B6, as well as may inhibit CYP2C9 and CYP2C19.[11] However, other in-vitro studies find no significant inhibition of CYP2C9.[9][131] Modafinil may induce P-glycoprotein, which may affect drugs transported by P-glycoprotein, such as digoxin.[132] It was clinically found that modafinil affects

endogenous substances:[133]

  • opioids, such as methadone, hydrocodone, oxycodone, or fentanyl – modafinil may result in a drop in opioid plasma concentrations because of faster clearance of opioids by CYP3A4. If the patient is not monitored closely, reduced efficacy or withdrawal symptoms can occur.[133]
  • human growth hormone or thyroid-stimulating hormone.[135][136] Since modafinil induces the activity of the CYP3A4 enzyme involved in cortisol clearance,[137] modafinil may reduce the bioavailability of hydrocortisone. Therefore, it may be necessary to adjust the steroid substitution dose in people receiving modafinil, which is a CYP3A4-metabolism-inducing drug.[138]

Pharmacology

Pharmacodynamics

Modafinil activity profile
Site Potency Type Species Refs
DATTooltip Dopamine transporter 1.8–2.6 μM
4.8 μM
6.4 μM
4.0 μM		 Ki
Ki
IC50a
IC50a		 Human
Rat
Human
Rat		 [139][140]
[139]
[141][142]
[139]
NETTooltip Norepinephrine transporter >10 μM
>92 μM
35.6 μM
136 μM		 Ki
Ki
IC50a
IC50a		 Human
Rat
Human
Rat		 [139][140]
[139]
[141][142]
[139]
SERTTooltip Serotonin transporter >10 μM
46.6 μM
>500 μM
>50 μM		 Ki
Ki
IC50a
IC50a		 Human
Rat
Human
Rat		 [139][140]
[139]
[141][142]
[139]
D2
 >10 μM
16 μMb
120 μMb		 Ki
Ki
EC50a		 Human
Rat
Rat		 [139]
[143]
[143]
Footnotes: a = Functional activity, not binding inhibition. b = Armodafinil at D2High. Notes: No activity at a variety of other assessed targets.[139]

The precise mechanism of action of modafinil for narcolepsy and other sleep disorders remains unclear.[3][113][144][145] Although modafinil may have interactions with neurotransmitter systems, its exact mode of action is not fully understood.[113][146]

From laboratory research, modafinil has little to no affinity for serotonin or norepinephrine transporters and does not directly interact with these systems.[16][145] However, studies have shown that elevated concentrations of norepinephrine and serotonin can occur as an indirect effect following modafinil administration due to increased extracellular dopamine activity.[145][16] Unlike traditional psychostimulant drugs, such as cocaine or amphetamine, modafinil shows low potential for causing euphoria due to differences in how it interacts with dopamine transporters at a cellular level.[113][145][146]

In addition to its influence on

hypocretin.[145] Orexin neurons play a crucial role in promoting wakefulness and regulating arousal states. Modafinil may increase signaling within hypothalamic orexin pathways, potentially contributing to its wake-promoting effects.[16][145]

Pharmacokinetics

Cmax (peak levels) occurs approximately 2 to 3 hours after modafinil administration.

plasma proteins at clinical concentrations of the drug. This percentage changes very little when the concentration of modafinil is varied.[147]

Renal excretion of unchanged modafinil usually accounts for less than 10% of an oral dose. This means that when modafinil is taken by mouth, less than 10% of the drug is eliminated from the body through the urine without being metabolized by the liver or other organs. The rest of the drug is either metabolized or excreted through other routes, such as feces or bile.[9]

The two major circulating metabolites of modafinil are modafinil acid (CRL-40467) and modafinil sulfone (CRL-41056). Both of these metabolites have been described as inactive, and neither appears to contribute to the wakefulness-promoting effects of modafinil.[57][148] However, modafinil sulfone does appear to possess anticonvulsant effects, a property that it shares with modafinil.[57][149]

Elimination half-life is in the range of 10 to 12 hours,[9][147] subject to differences in sex,[87] in cytochrome P450 genotypes, liver function and renal function. Modafinil is metabolized mainly in the liver,[9] and its inactive metabolites are excreted in the urine. Urinary excretion of the unchanged drug is usually less than 10%, but can range from 0% to as high as 18.7%, depending on the factors mentioned.[147]

Modafinil exhibits sex-specific pharmacokinetic differences.[87] It demonstrates higher bioavailability in women compared to men. The mean Cmax is higher in women than in men, 5.2 mg/L vs. 4.2 mg/L (p < 0.05), following a single 200 mg oral dose of modafinil.[87] This difference persists even after adjusting for body weight (0.88 ml/min/kg vs. 0.72 ml/min/kg).[87] The clearance of modafinil is 30% higher in men than in women, and plasma concentrations after a single dose are significantly higher in women than in men. These sex-specific pharmacokinetic differences may have implications for the efficacy and safety of modafinil.[87]

Chemistry

Enantiomers

Armodafinil ((R)-(−)-modafinil)
Esmodafinil ((S)-(+)-modafinil)

Modafinil is a racemic mixture of two enantiomers, armodafinil ((R)-modafinil) and esmodafinil ((S)-modafinil).[150]

Detection in body fluids

Modafinil and/or its major metabolite, modafinil acid, may be quantified in plasma, serum, or urine to monitor dosage in those receiving the drug therapeutically, to confirm a diagnosis of poisoning in hospitalized patients, or to assist in the forensic investigation of a vehicular traffic violation.[151] Instrumental techniques involving gas or liquid chromatography are usually employed for these purposes.[81][152][153] In 2011, modafinil was not tested for by common drug screens (except for anti-doping screens) and is unlikely to cause false positives for other chemically unrelated drugs such as substituted amphetamines.[142][150][154]

Reagent testing can screen for the presence of modafinil in samples.[155][156]

Colors produced by modafinil with various reagents
RC Marquis Reagent Liebermann Froehde
Modafinil Yellow/Orange > Brown[155][156] Darkening Orange[155] Deep orange/red[156]

Structural analogs

Many

lauflumide), and modafinil sulfone (CRL-41056).[159][20]

History

Modafinil was developed in France by neurophysiology professor Michel Jouvet and Lafon Laboratories. It is part of a series of benzhydryl sulfinyl compounds, including adrafinil, initially used as a treatment for narcolepsy in France in 1986.[160] Modafinil, the primary metabolite of adrafinil,[161] has been prescribed in France since 1994 under the name Modiodal,[160] and in the United States since 1998 as Provigil.[8] Unlike modafinil, adrafinil does not have FDA approval and was withdrawn from the French market in 2011.[162]

The FDA approved modafinil in 1998 for narcolepsy treatment, and later for shift work sleep disorder and obstructive sleep apnea in 2003.[8][163][164] It was approved in the UK in December 2002. In the United States, modafinil is marketed by Cephalon,[165] who acquired the rights from Lafon and purchased the company in 2001.[165]

Cephalon introduced armodafinil, the (R)-enantiomer of modafinil, in the United States in 2007. Generic versions of modafinil became available in the US in 2012 after extensive patent litigation.[166][167]

Society and culture

Modafinil is not approved for use by children in multiple jurisdictions.[1][168][7][8][169]

Legal status

Australia

In Australia, modafinil is considered to be a

prescription-only medicine. This means that it is a drug with a perceived low potential for abuse and low risk of dependence; still, the use of Schedule 4 drugs in Australia is restricted to those who have a valid prescription from a medical practitioner; import from abroad is illegal.[170]

Canada

In Canada, modafinil is not specifically included in the lists of controlled drugs and substances specified within the Controlled Drugs and Substances Act.[171] However, it is classified as a Schedule F prescription drug.[172][173][174] This means that modafinil can only be obtained legally with a valid prescription from a licensed health care practitioner in Canada, and the import of modafinil to Canada from other countries is subject to restrictions: importing prescription drugs without an import permit may result in the seizure of the drugs at the border, the refusal of entry of the drugs into Canada, or prosecution.[175]

China

In mainland China, modafinil is strictly controlled like other stimulants such as amphetamines and methylphenidate. It is classified as Class I psychotropic drug. This classification means that modafinil is considered to have a high potential for abuse and dependence, and is therefore subject to strict regulation and control. As a result, modafinil is only available by prescription and cannot be purchased over the counter. In order to obtain a prescription for modafinil, a patient must have a valid medical reason for using the drug, such as narcolepsy or obstructive sleep apnea. Additionally, the prescription must be written by a licensed physician and filled at a licensed pharmacy. The use of modafinil for non-medical purposes, such as with the aim to improve cognitive performance or to stay awake for long periods of time, is strictly prohibited and can result in legal consequences.[176][177]

Europe

In Denmark, modafinil is a prescription drug but not listed as a controlled substance. According to the Danish Medicines Agency, modafinil is approved for use in the treatment of narcolepsy, still, importing modafinil to Denmark is considered illegal without a valid prescription.[178][179][180][181]

In Finland, modafinil is a prescription drug but not listed as a controlled substance. Finland is a member of the European Union, and it is illegal to import prescription medicine from outside the European Union unless the person has a valid prescription.[182][183][184]

In the Republic of Moldova, modafinil is classified as a psychotropic drug (included in table III list 3 which is the list of psychotropic substances as defined by the Government of Moldova)[185] and is available by prescription.[185] Importation of modafinil may be considered illegal and subject to severe penalties, even if you have a prescription.[186] For example, on June 29, 2017, Moldovan postal officers discovered 60 tablets of Modalert (200 mg modafinil tablets) in a parcel sent from India to a resident in Chișinău, Moldova. The prohibited substance was detected during a routine scan and was seized as illegal. The authorities were notified of the incident and the recipient was charged with criminal penalties.[187][188] In the Transnistria region of Moldova, modafinil is completely prohibited, due to application of the legislation similar to that of Russia where modafinil is completely prohibited and is in the same list as narcotics. Possession or an attempt to bring modafinil to Transnistria potentially leads to imprisonment.[189]

In Romania, modafinil is classified as a stimulant doping agent and is prohibited in sports competitions.[190] In 2022, laws were passed making its importation or sale a felony, punishable by three to seven years in jail.[191] Simple possession for personal use may result in a fine and confiscation.[191]

In Sweden, modafinil is classified as a schedule IV substance, which means that it is considered to have low potential for abuse and low risk of dependence. Still, possession is illegal without prescription.[192]

In the United Kingdom, it is not listed in Misuse of Drugs Act, so possession is not illegal, but a prescription is required.[193]

Mexico

In Mexico, modafinil is not listed as a controlled substance, in the National Health Law, and can be purchased in pharmacies without prescription.[194]

Japan

In Japan, modafinil is Schedule I psychotropic drug. This means that it is considered to have a high potential for abuse and dependence, and is therefore subject to strict regulations. The use of Schedule I drugs in Japan is generally prohibited, except under certain circumstances, such as for medical purposes. It can only be prescribed by a doctor. It cannot be imported or exported without a permit. It cannot be used while driving or operating machinery.[195][196] Cephalon licensed Alfresa Corporation to produce, and Mitsubishi Tanabe Pharma to sell modafinil products under the trade name Modiodal in Japan.[197] There have been arrests of people who imported modafinil for personal use.[198][199]

Russia

In Russia, starting from May 18, 2012, modafinil is Schedule II controlled substance. Being classified as a schedule II controlled substance in Russia means that it is seen as a drug with a high potential for abuse and dependence. This classification imposes strict regulations on the production, distribution, and use of modafinil. Possession of a few modafinil pills can lead to three to ten years imprisonment. Modafinil is not approved for medical use in Russia and cannot be bought even in pharmacies. It also cannot be imported from abroad, even if you have a prescription issued outside Russia.[189][200] There are multiple cases of criminal proceedings initiated against Russian residents who tried to import modafinil by mail from abroad.[201][202]

South Africa

In South Africa, modafinil is Schedule V substance, which means that it is legal to use modafinil in South Africa, but only with a valid prescription from a licensed medical practitioner.[203]

United States

In the United States, modafinil is classified as a schedule IV controlled substance[2] under US federal law.[8][204] This means that the drug has a low potential for abuse and dependence compared to other controlled substances. However, it still requires a prescription from a licensed healthcare provider to obtain.[204]

It is illegal to import modafinil to the United States without a Drug Enforcement Administration (DEA)-registered importer and a prescription.[205] Individuals may legally bring modafinil into the US from a foreign country for personal use, limited to 50 dosage units, with a prescription and proper declaration at the border.[206] Under the Pure Food and Drug Act, marketing drugs for off-label uses is prohibited.[207] Cephalon, the manufacturer of Provigil, faced legal issues for promoting off-label uses and paid significant fines in 2008.[208]

Brand names

A generic formulation of modafinil marketed under the Aspendos brand name

Modafinil is sold under a variety of brand names worldwide, including Alertec, Alertex, Altasomil, Aspendos, Bravamax, Forcilin, Intensit, Karim, Mentix, Modafinilo, Modalert, Modanil, Modasomil, Modvigil, Modiodal, Modiwake, Movigil, Provigil, Resotyl, Stavigile, Vigia, Vigicer, Vigil, Vigimax, Waklert, and Zalux.[209]

Economics

Originally developed in the 1970s by French neuroscientist Michel Jouvet and Lafon Laboratories, modafinil has been prescribed in France since 1994,[160][29] and was approved for medical use in the United States in 1998.[8][29]

Concerns have been raised about the growing use of modafinil as a "smart drug" or cognitive enhancer among healthy individuals who use it with the aim to improve concentration and memory.[210][211] In 2003, modafinil sales were skyrocketing, with some experts concerned that it had become a tempting pick-me-up for people looking for an extra edge in a productivity-obsessed society.[210] The cost of modafinil varied depending on factors such as location and insurance coverage,[210][211][212] still, in 2004, the price of modafinil in the US was around $120 or more per monthly supply.[210] However, the availability of generic versions has increased since then and may have driven down prices.[210][211][212]

In 2020, modafinil was the 302nd most commonly prescribed medication in the United States, with just over 1000000 prescriptions.[213]

As of 2024, the global sales figures for modafinil are not known. Still, modafinil sold under the brand name Provigil accounted for over 40% of Cephalon's global turnover for several years, according to the information published in 2020.[214]

Patent protection and litigation

Modafinil's patent history involves several key developments. The original patent, U.S. patent 4,927,855, was granted to Laboratoire L. Lafon in 1990, covering the chemical compound of modafinil. This patent expired in 2010.[215] In 1994, Cephalon filed a patent for modafinil in the form of particles of a defined size, represented by U.S. patent 5,618,845, which expired in 2015.[216]

Following the nearing expiration of marketing rights in 2002, generic manufacturers, including Mylan and Teva, applied for FDA approval to market a generic form of modafinil, leading to legal challenges by Cephalon regarding the particle size patent.[217] The patent RE 37,516 was declared invalid and unenforceable in 2011.[218]

In addition, Cephalon entered agreements with several generic drug manufacturers to delay the sale of generic modafinil in the US. These agreements were subject to legal scrutiny and antitrust investigations, culminating in a ruling by the Court of Appeals in 2016, which found that the settlements did not violate antitrust laws.[219]

Sports

The regulation of modafinil as a doping agent has been controversial in the sporting world, with high-profile cases attracting press coverage since several prominent American athletes tested positive for the substance. Some athletes who used modafinil protested that the drug was not on the prohibited list at the time of their offenses.[220] However, the World Anti-Doping Agency (WADA) maintains that modafinil was related to already-banned substances. The Agency added modafinil to its list of prohibited substances on August 3, 2004, ten days before the start of the 2004 Summer Olympics.[154]

Several athletes (such as sprinter

doping agent. Taurasi and another player—Monique Coker, tested at the same lab—were later cleared.[225] Kelli White, who tested positive after her 100m victory at the 2003 World Championships in Paris, was stripped of her gold medals.[226] She claimed that she used modafinil to treat narcolepsy, but the International Association of Athletics Federations (IAAF) ruled that modafinil was a performance-enhancing drug.[226]

The

human growth hormone.[227]

Social views

The use of modafinil as a supposed cognitive enhancer may be considered as cheating, unnatural, or risky.

Wall Street trading may not view the use of modafinil as cheating, believing that if modafinil can give them an edge and they are aware of the risks involved, it should not be considered as cheating.[231] Due to such varying views, modafinil users for narcolepsy may cope with stigma by hiding, denying, or justifying their use, or by seeking support from others who share their views or experiences.[232][233]

Research

Psychiatric conditions

Major depressive disorder

Modafinil has been studied in the treatment of

network meta-analysis, modafinil and most other stimulants did not significantly improve depression, with only methylphenidate remaining effective.[236] Modafinil and other stimulants likewise did not improve quality of life in the meta-analysis, although there was evidence for reduced fatigue and sleepiness with modafinil and other stimulants.[236] While significant effectiveness of modafinil for depression has been reported by particular trials,[62][235][237] reviews and meta-analyses note that the effectiveness of modafinil for depression is limited, the quality of available evidence is low, and the results are inconclusive.[236][238][239]

Attention deficit hyperactivity disorder (research)

Modafinil was considered for the treatment of ADHD because of its lower

abuse potential than conventional psychostimulants like methylphenidate and amphetamines.[46][240] In 2008, an application to market modafinil for pediatric ADHD was submitted to the Food and Drug Administration in the US.[98][55]

However, evidence of modafinil for treatment of adult ADHD is mixed, and a 2016 systematic review of alternative drug therapies for adult ADHD did not recommend its use in this context.

phase 3 clinical trial of modafinil for adult ADHD, modafinil was not effective in improving symptoms, andhil there was a high rate of side effects (86%) and discontinuation (47%).[241] The poor tolerability of modafinil in this study was possibly due to the use of high doses (210–510 mg/d).[241] Another reason for the denial of the approval was due to concerns about rare but serious dermatological toxicity in Stevens–Johnson syndrome).[98]

Substance dependence

Modafinil was studied for the treatment of

stimulant dependence, but the results are mixed and inconclusive.[20][242] Modafinil is not a controlled substance in some countries, unlike other medications, such as bupropion, which is also used to treat depression and nicotine dependence.[243] The clinical trials that have tested modafinil as a treatment for stimulant abuse have failed to demonstrate its efficacy and the optimal dose and duration of modafinil treatment remain unclear, and modafinil is not a recommended treatment for stimulant abuse.[243]

Schizophrenia

Modafinil and armodafinil were studied as a complement to antipsychotic medications in the treatment of schizophrenia. They showed no effect on positive symptoms or cognitive performance.[244][245] A 2015 meta-analysis found that modafinil and armodafinil may slightly reduce negative symptoms in people with acute schizophrenia, though they do not appear useful for people with the condition who are stable, with high negative symptom scores.[245] Among medications demonstrated to be effective for reducing negative symptoms in combination with antipsychotics, modafinil and armodafinil are among the smallest effect sizes.[246]

Abstinence in cocaine addiction

Modafinil is researched as a remedy to improve abstinence in people with

cocaine addiction.[247] Morning-dosed modafinil has been shown to normalize sleep parameters in individuals experiencing cocaine withdrawal.[248]

Cognitive enhancement

A 2019 review conducted on the potential nootropic effects of modafinil in healthy, non-sleep-deprived individuals revealed the following:

executive function
, only half of these studies showed improvements in attention, learning, and memory, with a few studies even reporting impairments in divergent creative thinking; b) modafinil displayed small levels of enhancement in attention, executive functions, and learning abilities; c) no substantial side effects or mood changes were observed; d) the available evidence showed limited evidence for modafinil as a cognitive enhancer outside of its use for sleep-deprived populations.

A 2020 review reported that modafinil has a modest effect on memory updating, but the effect is small and may not accurately reflect the perception that it is useful as a cognitive enhancer, as there is insufficient evidence to support such a claim.[250]

Post-anesthesia sedation

General anesthesia is required for many surgeries, but may cause lingering fatigue, sedation, and/or drowsiness after surgery that lasts for hours to days.[251][252] In outpatient surgery the sedation, fatigue, and occasional dizziness is problematic.[253][254] Modafinil was tested as a potential remedy to alleviate these symptoms.[45] For example, it was expected that modafinil would help people recover quicker from general anesthesia after a short surgery,[98] but the results were uncertain and the inconclusive studies could not reliably verify the expectation.[45] The use of modafinil to relieve post-anesthesia sedation is investigational.[98]

Postural orthostatic tachycardia syndrome

Caution should be exercised in people who have narcolepsy in comorbidity with

CNS depressant which makes it an alternative drug for stimulant-intolerant people with POTS.[256][257]

Inflammation

A possible link between inflammatory processes and depressive disorders[258] has stimulated preliminary research on modafinil for its potential anti-inflammatory effects.[259]

References

  1. ^ a b c "TGA eBS - Product and Consumer Medicine Information Licence". Archived from the original on February 28, 2024. Retrieved February 28, 2024.
  2. ^ a b c d e f Sapienza F (January 27, 1999). "64 FR 4050 - Schedules of Controlled Substances: Placement of Modafinil Into Schedule IV". Federal register. Department of Justice. Archived from the original on February 5, 2024. Retrieved February 5, 2024.
  3. ^ a b c d e f g h i j "Modafinil Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. September 23, 2023. Archived from the original on March 30, 2019. Retrieved February 3, 2024.
  4. FDA
    . Retrieved October 22, 2023.
  5. ^ "RDC Nº 784 – Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 – Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published April 4, 2023). March 31, 2023. Archived from the original on August 3, 2023. Retrieved August 3, 2023.
  6. ^ "Modafinil Product information". Health Canada. April 25, 2012. Archived from the original on June 10, 2022. Retrieved June 10, 2022.
  7. ^ a b "Modafinil Provigil 100 mg Tablets – Summary of Product Characteristics (SMPC) – (Emc)". emc. June 9, 2021. Archived from the original on December 2, 2023. Retrieved December 1, 2023.
  8. ^ a b c d e f g h i j k l m n o p q r s t u "Provigil- modafinil tablet". DailyMed. November 30, 2018. Archived from the original on June 10, 2022. Retrieved June 10, 2022.
  9. ^
    S2CID 1266677
    .
  10. ^
    PMID 22375280
    .
  11. ^
    PMID 10820139
    .
  12. ^ a b c "Modafinil". MedlinePlus. US National Library of Medicine. February 15, 2016. Archived from the original on December 7, 2023. Retrieved February 3, 2024.
  13. ^
    PMID 33074297
    .
  14. ^
    ISSN 0013-0613. Archived
    from the original on December 3, 2023. Retrieved December 3, 2023.
  15. ^
    ISSN 0362-4331. Archived
    from the original on December 3, 2023. Retrieved December 3, 2023.
  16. ^
    NCBI NBK531476
    .
  17. ^
    S2CID 252046371
    .
  18. ^
    PMID 32341841
    .
  19. PMID 34743789
    .
  20. ^
    PMID 32927246
    .
  21. ^
    S2CID 231593912
    .
  22. S2CID 251107306
    .
  23. S2CID 241205299
    .
  24. ^ a b "Modafinil (Provigil): Now restricted to narcolepsy". Medicines and Healthcare products Regulatory Agency. Archived from the original on December 15, 2023. Retrieved December 2, 2023.
  25. S2CID 1906751
    .
  26. PMID 18041479
    .
  27. S2CID 257214950
    .
  28. ^
    PMID 37839272
    .
  29. ^ "Multiple sclerosis in adults: Management, Guidance". The National Institute for Health and Care Excellence (NICE). June 22, 2022. Archived from the original on September 5, 2022. Retrieved September 5, 2022.
  30. ^ "Provigil". National Multiple Sclerosis Society. Archived from the original on September 5, 2022. Retrieved September 6, 2022.
  31. PMID 35572947
    .
  32. PMID 34856949
    .
  33. ^
    PMID 37445551
    .
  34. ^
    PMID 15893683
    .
  35. ^
    S2CID 207263842
    .
  36. ^
    PMID 29175676
    .
  37. S2CID 189861826
    .
  38. S2CID 231723198. Archived
    (PDF) from the original on October 21, 2023. Retrieved October 19, 2023.
  39. PMID 29952165
    .
  40. S2CID 52019992
    .
  41. ^
    S2CID 33004517
    .
  42. PMID 30097390
    .
  43. S2CID 221329069
    .
  44. ^
    PMID 16669720
    .
  45. ^
    S2CID 24293088
    .
  46. S2CID 37368284
    .
  47. PMID 22303520
    .
  48. ^
    ISBN 978-3-030-62058-5
    .
  49. PMID 22717304
    .
  50. ^
    S2CID 2932701
    .
  51. PMID 30069121
    .
  52. ^
    PMID 31643130
    .
  53. PMID 36561896
    .
  54. ^
    PMID 38433530
    .
  55. ^ a b "Modafinil in the treatment of selected mental disorders". ProQuest. Archived from the original on February 14, 2024. Retrieved February 14, 2024.
  56. ^
    S2CID 210709160
    .
  57. S2CID 204028869
    .
  58. ^
    S2CID 237485915
    .
  59. S2CID 257665446
    .
  60. PMID 20492846
    .
  61. ^
    PMID 25295426
    .
  62. ^ Hughes S (February 1991). "Drugged troops could soldier on without sleep". New Scientist. Archived from the original on January 22, 2021. Retrieved December 2, 2023.
  63. ^
    PMID 34632515
    .
  64. ^
    S2CID 256621326
    .
  65. ^ Gonzalez J (July 2017). "Go Pills for Black Shoes?". U.S. Naval Institute Proceedings. 143 (7/1, 373). Archived from the original on December 3, 2023. Retrieved December 3, 2023.
  66. PMID 16018329
    .
  67. ^ Sample I, Evans R (July 29, 2004). "MoD bought thousands of stay awake pills in advance of war in Iraq". The Guardian. Archived from the original on December 2, 2023. Retrieved December 2, 2023.
  68. ISSN 1059-1028. Archived
    from the original on October 17, 2020. Retrieved May 23, 2019.
  69. ^ "Air Force Special Operations Command Instruction 48–101" (PDF). November 30, 2012. Archived from the original (PDF) on April 10, 2018. (sects. 1.7.4), U.S. Air Force Special Operations Command
  70. PMID 19487390
    .
  71. ^ Cadwalladr C (February 14, 2015). "Students used to take drugs to get high. Now they take them to get higher grades". The Guardian. Archived from the original on August 3, 2020. Retrieved January 7, 2017.
  72. ISSN 0013-0613. Archived
    from the original on December 3, 2023. Retrieved December 3, 2023.
  73. ^ "Professors are taking the same 'smart drugs' as students to keep up with workloads". The Independent. May 30, 2017. Archived from the original on December 7, 2022. Retrieved January 17, 2023.
  74. ^ Talbot M. "Brain Gain". The New Yorker. Archived from the original on August 19, 2020. Retrieved April 9, 2017.
  75. ISSN 0013-0613. Archived
    from the original on December 3, 2023. Retrieved December 3, 2023.
  76. S2CID 236402826
    .
  77. ISSN 0013-0613. Archived
    from the original on December 3, 2023. Retrieved December 3, 2023.
  78. PMID 17712350
    .
  79. PMID 12417966
    .
  80. ^
    S2CID 43733424
    .
  81. ISBN 978-0-19-872739-2
    .
  82. S2CID 23319688
    .
  83. ^
    S2CID 247860331
    .
  84. ISBN 978-1-4939-2088-4
    .
  85. ^ a b "Modafinil (Provigil): increased risk of congenital malformations if used during pregnancy". GOV.UK. November 16, 2020. Archived from the original on January 13, 2024. Retrieved January 13, 2024.
  86. ^
    doi:10.1007/s40675-016-0060-1
    .
  87. ^
    S2CID 224780160
    .
  88. PMID 32870289
    .
  89. ^ a b Miller M, et al. (Hull & East Riding Prescribing Committee). Morgan J (ed.). "Prescribing Framework for Modafinil for Daytime Hypersomnolence and excessive daytime sleepiness in Parkinsons" (PDF). Northern Lincolnshire, UK: National Health Service. Archived (PDF) from the original on December 2, 2023. Retrieved December 2, 2023.
  90. ^ a b "Modafinil for the treatment of adult patients with excessive sleepiness" (PDF). National Health Service, UK. November 10, 2022. Archived (PDF) from the original on December 2, 2023. Retrieved December 2, 2023.
  91. ^ "The Safety of Stimulant Medication Use in Cardiovascular and Arrhythmia Patients". Archived from the original on January 29, 2024. Retrieved January 29, 2024.
  92. ^ "Modafinil: Annex III Summary of Product Characteristics, Labelling and Package Leaflet" (PDF). European Medicines Agency. Archived (PDF) from the original on January 29, 2024. Retrieved January 29, 2024.
  93. PMID 16199853
    .
  94. S2CID 9192971
    .
  95. S2CID 10265746
    .
  96. ^ Evans K, Tay S (September 2020). "Shared Care Guideline – Modafinil for narcolepsy (adults) and excessive daytime sleepiness in Parkinson's disease" (PDF). York and Scarborough Medicines Commissioning Committee. Archived (PDF) from the original on January 30, 2024. Retrieved January 30, 2024.
  97. ^
    S2CID 38542387
    .
  98. ISSN 0378-6080
    .
  99. ^ "Australian Adverse Drug Reactions Bulletin 2008". Australian Adverse Drug Reactions Bulletin. December 1, 2008. Archived from the original on July 3, 2020.
  100. ^ "Provigil" (PDF). Medication Guide. Cephalon, Inc. November 1, 2010. Archived from the original (PDF) on March 4, 2016. Retrieved December 31, 2013.
  101. NCBI NBK548274
    .
  102. ^ "Modafinil (marketed as Provigil): Serious Skin Reactions". U.S. Food and Drug Administration (FDA). 2007. Archived from the original on January 15, 2009.
  103. ^ Li TW (November 6, 2023). "Three men hospitalised after taking modafinil or armodafinil to stay awake; drugs were not prescribed". The Straits Times. Archived from the original on December 3, 2023. Retrieved December 3, 2023.
  104. ^
    PMID 15336235
    .
  105. ^ "FDA Provigil Drug Safety Data" (PDF). U.S. Food and Drug Administration (FDA). January 2015. Archived (PDF) from the original on May 2, 2017.
  106. PMID 19300563
    .
  107. ^
    S2CID 235648766
    .
  108. S2CID 52143478
    .
  109. ISBN 978-3-319-46435-0
    .
  110. ^
    PMID 33802176
    .
  111. ^
    PMID 23065655
    .
  112. ^
    S2CID 203405397
    .
  113. S2CID 151797528
    .
  114. PMID 22542906
    .
  115. PMID 16741217
    .
  116. PMID 35990796
    .
  117. ^ "Yellow List: List of Narcotic Drugs Under International Control". In accordance with the Single Convention on Narcotic Drugs, 1961 [Protocol of March 25, 1972, amending the Single Convention on Narcotic Drugs, 1961] (59th ed.). International Narcotics Control Board. July 2020. Archived from the original on January 16, 2022. Retrieved January 12, 2022.
  118. ^ "Green List: List of Psychotropic Substances Under International Control". In accordance with Convention psychotropic substances of 1971 (31st ed.). International Narcotics Control Board. July 2020. Archived from the original on January 18, 2022. Retrieved January 12, 2022.
  119. ^
    S2CID 201063075
    .
  120. S2CID 204987385
    .
  121. S2CID 195079873
    .
  122. doi:10.1111/j.1527-3458.1999.tb00100.x
    .
  123. S2CID 221495887
    .
  124. ^
    PMID 23757186
    .
  125. S2CID 195081462
    .
  126. S2CID 12421545
    .
  127. ^ "Modafinil Interactions". Drugs.com. January 10, 2024. Archived from the original on December 15, 2023. Retrieved February 5, 2024.
  128. ^ a b "Drug Development and Drug Interactions | Table of Substrates, Inhibitors and Inducers". U.S. Food and Drug Administration (FDA). May 26, 2021. Archived from the original on November 4, 2020. Retrieved April 8, 2022.
  129. ^ "Cytochrome P450 3A (including 3A4) inhibitors and inducers". UpToDate. Archived from the original on April 8, 2022. Retrieved April 8, 2022.
  130. S2CID 29223738
    .
  131. PMID 17963743
    .
  132. ^ a b "Modafinil drug interactions". Drugs.com. Archived from the original on May 3, 2021. Retrieved May 3, 2021.
  133. ^ "Modafinil". Medline Plus. U.S. National Library of Medicine. July 1, 2005. Archived from the original on June 10, 2007. Retrieved July 21, 2007.
  134. S2CID 13752498
    .
  135. S2CID 8033437
    .
  136. S2CID 5791536
    .
  137. PMID 34633961
    .
  138. ^
    PMID 19197004
    .
  139. ^
    PMID 34423920
    .
  140. ^
    PMID 29115823
    .
  141. ^
    PMID 22537794
    .
  142. ^
    S2CID 17758902
    .
  143. ISBN 978-1-108-22874-9
    .
  144. ^
    PMID 19300566
    .
  145. ^
    PMID 28646346
    .
  146. ^
    ISBN 978-0-07-135469-1
    .
  147. S2CID 34069997
    .
  148. S2CID 956077
    .
  149. ^
    PMID 20307223
    .
  150. ISSN 2413-6158. Archived
    from the original on September 28, 2020. Retrieved February 6, 2024.
  151. S2CID 26877375
    .
  152. ISBN 978-0-9626523-7-0
    .
  153. ^
    doi:10.3390/chemosensors10080324
    .
  154. ^ a b c Spratley TK, Hayes PA, Geer LC, Cooper SD, McKibben TD (2005). "Analytical Profiles for Five "Designer" Tryptamines" (PDF). Microgram Journal. 3 (1–2): 54–68. Archived (PDF) from the original on August 2, 2020. Retrieved December 18, 2015.
  155. ^ a b c "Modafinil reaction with the Froehde reagent and others". Reagent Tests UK. December 13, 2015. Archived from the original on August 3, 2020. Retrieved December 18, 2015.
  156. PMID 18954992
    .
  157. PMID 24494745
    .
  158. PMID 33024436
    .
  159. ^
    S2CID 237863162. Archived
    (PDF) from the original on January 8, 2022. Retrieved February 2, 2024.
  160. S2CID 32939239
    .
  161. ^ "Adrafinil". The Governors of the University of Alberta. May 14, 2021. Archived from the original on May 16, 2021. Retrieved May 14, 2021.
  162. ^ "Drug Approval Package: Provigil (Modafinil) NDA# 20717". U.S. Food and Drug Administration (FDA). September 10, 2001. Archived from the original on March 1, 2024. Retrieved March 1, 2024.
  163. PMID 22363762
    .
  164. ^ a b "Cephalon: Modafinil – Pharmaceutical industry news". The Pharma Letter. October 8, 1995. Archived from the original on November 15, 2023. Retrieved November 15, 2023.
  165. PMID 24773330
    .
  166. ^ "Generic Provigil Availability". Drugs.com. November 2023. Archived from the original on November 15, 2023. Retrieved November 15, 2023.
  167. ^ "Product monograph including patient medication information Alertec modafinil tablets, 100 mg, oral mfr. std. central nervous system stimulant" (PDF). Archived (PDF) from the original on February 21, 2024. Retrieved February 28, 2024.
  168. ^ "Modafinil". European Medicines Agency. November 18, 2010. Archived from the original on January 20, 2024. Retrieved February 28, 2024.
  169. ^ "Poisons Standard March 2018". Legislation.gov.au. February 28, 2018. Archived from the original on August 7, 2020. Retrieved January 20, 2019.
  170. ^ "Regulations Amending the Food and Drug Regulations (1184 — Modafinil)". Canada Gazette. Vol. 140, no. 20. March 26, 2005. Archived from the original on July 6, 2011.
  171. ^ Canada H (May 29, 2013). "Guidance Document: Determining Prescription Status for Human and Veterinary Drugs". www.canada.ca. Archived from the original on February 8, 2024. Retrieved February 8, 2024.
  172. ^ Canada H (May 29, 2013). "The Prescription Drug List". www.canada.ca. Archived from the original on June 28, 2023. Retrieved February 8, 2024.
  173. ^ Canada H (May 30, 2013). "Questions and Answers - Prescription Drug List". www.canada.ca. Archived from the original on February 8, 2024. Retrieved February 8, 2024.
  174. ^ "Bringing health products into Canada for personal use (GUI-0116)". December 23, 2020. Archived from the original on January 29, 2024. Retrieved January 29, 2024.
  175. ^ "食品药品监管总局 公安部 国家卫生计生委关于公布麻醉药品和精神药品品种目录的通知" [Notice from the Food and Drug Administration, the Ministry of Public Security, and the National Health and Family Planning Commission on publishing the catalog of narcotic drugs and psychotropic drugs] (in Chinese). China Food and Drug Administration. Archived from the original on December 5, 2018.
  176. ^ "处方管理办法(原卫生部令第53号)" [Prescription Management Measures (Former Ministry of Health Order No. 53)]. 中国政府网 (China Government Network) (in Chinese). Archived from the original on February 8, 2020. Retrieved February 8, 2019.
  177. ^ "Bekendtgørelse om euforiserende stoffer" [Narcotics act]. Retsinformation.dk (in Danish). June 23, 2020. Archived from the original on November 28, 2020. Retrieved October 7, 2020.
  178. ^ "Are you bringing medicine into Denmark?". Danish Medicines Agency. August 13, 2018. Archived from the original on January 26, 2024. Retrieved February 5, 2024.
  179. ^ "Medicines imported from abroad". Danish Medicines Agency. March 16, 2022. Archived from the original on January 26, 2024. Retrieved February 5, 2024.
  180. ^ "BEK nr 557 af 31/05/2011, Indenrigs- og Sundhedsministeriet". Civilstyrelsen. May 31, 2011. Archived from the original on January 26, 2024. Retrieved February 5, 2024.
  181. ^ "Lääkealan turvallisuus- ja kehittämiskeskuksen päätöslääkeluettelosta". Finlex.fi. 2009. Archived from the original on August 23, 2020. Retrieved January 3, 2017.
  182. ^ "Prohibited goods". Finnish Customs. Archived from the original on January 26, 2024. Retrieved February 5, 2024.
  183. ^ Dopinglinkki (September 19, 2019). "Modafinil". A-klinikkasäätiö. Archived from the original on January 26, 2024. Retrieved February 5, 2024.
  184. ^ a b "Hotărâre Nr. 79 din 23-01-2006 privind aprobarea Listei substanţelor stupefiante, psihotrope şi a plantelor care conţin astfel de substanţe depistate în trafic ilicit, precum şi cantităţile acestora" [Decision No. 79 of 01-23-2006 regarding the approval of the List of narcotic, psychotropic substances and plants containing such substances detected in illicit traffic, as well as their quantities] (in Romanian). Moldavian Ministry of Justice. January 23, 2006. Archived from the original on April 3, 2023. Retrieved February 5, 2024.
  185. ^ "Serviciul Vamal al Republicii Moldova – E bine să știm!" [Customs Service of the Republic of Moldova - Good to know!]. Customs Service of the Republic of Moldova (in Romanian). Archived from the original on September 4, 2023. Retrieved September 4, 2023.
  186. ^ Parfeni C (June 30, 2007). "Substanțe psihotrope și un pumnal militar au fost depistate de vameși în coletele poștale". curentul.md. Archived from the original on January 29, 2024. Retrieved January 29, 2024.
  187. ^ "Centrul de Sănătate din Edineţ va fi eficientizat energetic". noi.md. June 30, 2017. Archived from the original on January 29, 2024. Retrieved January 29, 2024.
  188. ^ a b "Decree of the Government of the Russian Federation of 06.30.1998 N 681 (as amended on 02.26.2013) "On approval of the list of narcotic drugs, psychotropic substances and their precursors subject to control in the Russian Federation"" (PDF). base.consultant.ru (in Russian). Archived from the original on August 28, 2021. Retrieved January 3, 2017.
  189. ^ "LISTA INTERZISĂ - 2018" [Forbidden List - 2018] (PDF). AGENȚIA NAȚIONALĂ ANTI-DOPING [National Anti-Doping Agency] (in Romanian). Archived from the original (PDF) on February 24, 2021.
  190. ^ a b "LEGE 219 26/07/2021" [Law 219 26/07/2021 -]. Portal Legislativ [Romanian Legislative Portal] (in Romanian). Archived from the original on October 16, 2022. Retrieved October 16, 2022.
  191. ^ "Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika" [The Swedish Medicines Agency's regulations (LVFS 2011: 10) on lists of drugs] (PDF) (in Swedish). Archived from the original (PDF) on August 7, 2019.
  192. ^ MHRA (April 3, 2013). "MHRA license for Modafinil in UK" (PDF). London: MHRA. Archived (PDF) from the original on January 22, 2016. Retrieved April 3, 2013.
  193. ^ "Estupefacientes y Psicotrópicos" [Narcotic Drugs and Psychotropic Substances] (in Spanish). Federal Commission for Protection against Health Risks. Archived from the original on July 13, 2007.
  194. ^ "List of psychotropics" (PDF). Narcotics Control Department. Archived from the original (PDF) on July 11, 2019. Retrieved May 24, 2019.
  195. ^ "モダフィニルの向精神薬への指定" [Designation as a psychotropic drug of Modafinyl] (in Japanese). Archived from the original on May 15, 2015. Retrieved January 17, 2017.
  196. ^ "医疗用医薬品の添付文书情报-モディオダール锭100mg" [Attachment of drugs for doctors-Modio Dal 100mg]. 独立行政法人 医薬品医疗机器総合机 [Pharmaceuticals and Medical Devices Agency] (in Japanese). Archived from the original on February 9, 2019.
  197. ^ "モダフィニル密輸で逮捕された歯科医師, ダイエットに使用と供述(報道)" [Dentist who was arrested for Modafinyl smuggling, usage and confidence (report)]. Medicallaw.exblog.jp (in Japanese). Archived from the original on January 21, 2019. Retrieved January 20, 2019.
  198. ^ "向精神薬をインドから密輸入した男を逮捕" [Arrested a man who imported psychotropic drugs from India]. Hayabusa3.5ch.net (in Japanese). Archived from the original on January 21, 2019. Retrieved January 20, 2019.
  199. ^ "Россия начнет производить новый стимулятор на базе модафинила" [Russia will begin to produce a new stimulator based on modafinil]. medvestnik.ru (in Russian). Archived from the original on December 8, 2023. Retrieved December 8, 2023.
  200. ^ "В Петербурге завели дело из-за полученных по почте таблеток от сонливости" [In St. Petersburg, a case was started because of the pills received by mail from drowsiness]. РБК (RBC) (in Russian). February 19, 2020. Archived from the original on December 8, 2023. Retrieved December 8, 2023.
  201. ^ ""Вместо лечения — тюрьма". Россияне с редкими болезнями оказались в ловушке" ["Instead of treatment - a prison." Russians with rare diseases were trapped]. РИА Новости (Ria News) (in Russian). October 11, 2023. Archived from the original on December 8, 2023. Retrieved December 8, 2023.
  202. ^ SA Government (April 10, 2003). "GENERAL REGULATIONS MADE IN TERMS OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965, AS AMENDED Government Notice R510 in Government Gazette 24727 dated 10 April 2003. 22A/16/b; states that although import and export is restricted, possession is not illegal providing that a prescription is present" (PDF). Pretoria: SAFLII. Archived from the original (PDF) on April 22, 2016.
  203. ^
    ISBN 978-0-85711-298-9
    .
  204. United States Drug Enforcement Administration. Archived from the original
    on July 9, 2007. Retrieved July 21, 2007.
  205. ^ "USC 201 Section 1301.26 Exemptions from import or export requirements for personal medical use". United States Department of Justice. March 24, 1997. Archived from the original on February 3, 2007. Retrieved January 10, 2007.
  206. ^ "Prescription Drug Marketing Act of 1987 (PDMA), PL 100-293". U.S. Food and Drug Administration (FDA). Archived from the original on February 23, 2008.
  207. ^ Allison J (October 9, 2009). "Class Action Over Cephalon Off-Label Claims Tossed". Law360. Archived from the original on April 30, 2022. Retrieved January 12, 2022. Cephalon executives have repeatedly said that they do not condone off-label use of Provigil, but in 2002 the company was reprimanded by the FDA for distributing marketing materials that presented the drug as a remedy for tiredness, "decreased activity" and other supposed ailments. In 2008, Cephalon paid $425m and pleaded guilty to a federal criminal charge relating to its promotion of off-label uses for Provigil and two other drugs.
  208. ^ "Modafinil – International Brands". Drugs.com. Archived from the original on July 18, 2020. Retrieved January 8, 2017.
  209. ^ a b c d e O'Connor A (June 29, 2004). "Wakefulness Finds a Powerful Ally". The New York Times. Archived from the original on December 2, 2023. Retrieved December 2, 2023.
  210. ^ a b c Petrounin D (July 6, 2014). "European Students' Use of 'Smart Drugs' is Said to Rise". The New York Times. Archived from the original on December 2, 2023. Retrieved December 2, 2023.
  211. ^ a b Kanter J (June 19, 2013). "Europe Fines Drug Companies for Delaying Generics". The New York Times. Archived from the original on December 2, 2023. Retrieved December 2, 2023.
  212. ^ "Modafinil – Drug Usage Statistics". ClinCalc. Archived from the original on June 6, 2023. Retrieved October 7, 2022.
  213. ^ ""Pay-For-Delay": The EC fines Teva and Cephalon for delaying the market entry of a generic version of Modafinil". Cuatrecasas. Archived from the original on November 16, 2023. Retrieved November 16, 2023.
  214. ^ US 4927855 
  215. ^ "Cephalon gets six-month Provigil patent extension". Philadelphia Business Journal. March 28, 2006. Archived from the original on August 4, 2008. Retrieved July 21, 2007.
  216. ^ "Details for Patent: RE37516". Archived from the original on January 1, 2014. Retrieved November 29, 2009.
  217. ^ "Document 514 :: APOTEX, INC. v. CEPHALON, INC. et al". Pennsylvania Eastern District Court :: US Federal District Courts Cases :: Justia. October 31, 2010. Archived from the original on January 1, 2014. Retrieved July 4, 2012.
  218. ^ In re: Modafinil Antitrust Litigation (Court of Appeals, 3rd Circuit 2016).
  219. ^ "Prohibited List 2018" (PDF). The World Anti-Doping Code: International Standard. World Anti-Doping Agency. September 5, 2017. Archived from the original on July 3, 2021. Retrieved January 12, 2022.
  220. ISSN 0362-4331. Archived
    from the original on December 3, 2023. Retrieved December 3, 2023.
  221. ^ "Clinger given lifetime ban for second doping infraction". Cycling News. August 14, 2011. Archived from the original on October 13, 2014. Retrieved October 8, 2014.
  222. ^ "Taurasi tested positive for modafinil". The Washington Post. December 25, 2010. Archived from the original on October 6, 2014. Retrieved December 31, 2013.
  223. ^ "British rowers handed two-year bans for taking banned substances". The Guardian. November 23, 2015. Archived from the original on July 9, 2020. Retrieved December 15, 2016.
  224. ^ Voepel M (February 18, 2011). "Taurasi: 'I've lost 3 months of my career'". Archived from the original on October 6, 2015. Retrieved April 11, 2011.
  225. ^ a b "White guilty of doping". September 9, 2003. Archived from the original on November 15, 2023. Retrieved November 15, 2023 – via news.bbc.co.uk.
  226. ^ "Book alleges Bonds's drug use". CBC News. March 7, 2006. Archived from the original on January 27, 2024. Retrieved January 27, 2024.
  227. ^ Macnaughton O (March 16, 2016). "The rise of smart drugs". Tatler. Archived from the original on November 15, 2023. Retrieved November 15, 2023.
  228. ^ Farrell K (November 6, 2017). "We asked Sussex University if Modafinil is cheating". The Sussex Tab. Archived from the original on November 15, 2023. Retrieved November 15, 2023.
  229. S2CID 149138516. Archived
    (PDF) from the original on February 2, 2024. Retrieved February 2, 2024.
  230. ^ Robert K (March 29, 2013). "The Real Limitless Drug Isn't Just for Lifehackers Anymore". New York Magazine. Archived from the original on December 26, 2023. Retrieved March 16, 2024.
  231. PMID 32023288
    .
  232. S2CID 266008273.[permanent dead link
    ]
  233. S2CID 3740987
    .
  234. ^
    S2CID 27622964
    .
  235. ^
    PMID 34144366
    .
  236. PMID 24330897
    .
  237. S2CID 45341424
    .
  238. PMID 35174594
    .
  239. PMID 27810669
    .
  240. ^
    S2CID 53714228
    .
  241. PMID 34121988
    .
  242. ^
    S2CID 220150476
    .
  243. PMID 20816042
    .
  244. ^
    PMID 25306261
    .
  245. PMID 28514486
    .
  246. S2CID 4775658
    .
  247. PMID 20080983
    .
  248. S2CID 201119084
    .
  249. S2CID 220651670. Archived
    (PDF) from the original on February 20, 2022.
  250. doi:10.1136/sbmj.070256
    .
  251. PMID 34338712
    .
  252. PMID 12411816
    .
  253. PMID 11964610
    .
  254. PMID 16943900
    .
  255. PMID 36043022
    .
  256. PMID 37313107
    .
  257. PMID 27640518
    .
  258. S2CID 215807973
    .

External links

Wikimedia Commons has media related to Modafinil.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Modafinil&oldid=1220431644"